321 – 330 of 359
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
The 5alpha-Reductase Type II A49T and V89L High-Activity Allelic Variants are More Common in Men with Prostate Cancer Compared with the General Population.
- Contribution to journal › Article
-
Mark
Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
- Contribution to journal › Scientific review
-
Mark
Geographical variation in incidence of prostate cancer in Sweden - Survey from the National Prostate Cancer Register
- Contribution to journal › Article
-
Mark
A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.
- Contribution to journal › Article
-
Mark
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue
- Contribution to journal › Article
- 2004
-
Mark
Micturition problems in relation to quality of life in men with prostate cancer or benign prostatic hyperplasia - Comparison with men from the general population
- Contribution to journal › Article
-
Mark
Pathophysiology of bone metastases in prostate cancer
- Contribution to journal › Article
-
Mark
Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio
- Contribution to journal › Article
-
Mark
Structure, evolution and expression of glandular kallikrein genes
(2004)
- Thesis › Doctoral thesis (compilation)
-
Mark
An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6
- Contribution to journal › Article
